Prenetics CMO buys 30,000 PRE shares for $398.8K in open market

Prenetics Global Limited reported that its Chief Marketing Officer, Rahul Ramchand, bought 30,000 Class A ordinary shares on the open market on November 14, 2025.

Rhea-AI Filing Summary

Prenetics Global Limited reported that its Chief Marketing Officer, Rahul Ramchand, bought 30,000 Class A ordinary shares on the open market on November 14, 2025. He paid $13.29 per share, for a total purchase price of $398,821. Following this transaction, his total holdings increased to 75,553 Class A ordinary shares of the company. This filing simply records the executive share purchase and resulting ownership level.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What executive share purchase did PRE report in this Form 6-K?

Prenetics Global Limited reported that its Chief Marketing Officer, Rahul Ramchand, purchased 30,000 Class A ordinary shares in the open market.

At what price did the Prenetics (PRE) CMO buy shares and what was the total cost?

The Chief Marketing Officer bought the shares at $13.29 per share, for a total purchase price of $398,821.

How many Prenetics (PRE) shares does the CMO now own after the purchase?

After the transaction, Rahul Ramchand holds a total of 75,553 Class A ordinary shares of Prenetics Global Limited.

When did the Prenetics CMO complete this share purchase?

The share purchase by Prenetics Global Limited's Chief Marketing Officer took place on November 14, 2025.

What type of filing did Prenetics (PRE) use to disclose the CMO share purchase?

Prenetics Global Limited disclosed the Chief Marketing Officer's share purchase in a Form 6-K report of foreign private issuer.

How were the Prenetics (PRE) shares acquired by the CMO?

The 30,000 Class A ordinary shares were acquired by the Chief Marketing Officer in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/17/2025 - 06:10 AM EST Learn about SEC filing dates

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025

Commission File Number 001-41401

Prenetics Global Limited

11401 Granite St. Charlotte, NC 28273 USA Unit 703-706, K11 Atelier 728 King’s Road, Quarry Bay Hong Kong

(Addresses of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.  Form 20-F  Form 40-F 

EXPLANATORY NOTE

Prenetics Global Limited (the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, furnishes this Form 6-K to announce that on November 14, 2025 its Chief Marketing Officer, Rahul Ramchand, purchased 30,000 shares of the Company's Class A Ordinary Shares at a price of $13.29 per share in the open market for a total purchase price of $398,821, bringing his total holdings to 75,553 Class A Ordinary Shares.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			Prenetics Global Limited
			By:			/s/ Lo Hoi Chun
			Name:			Lo Hoi Chun
			Title:			Chief Financial Officer
Date: November 17, 2025